Phylogenetic analysis alone cannot prove source of HIV infection: experts.

HIV AIDS Policy Law Rev

Canadian HIV/AIDS Legal Network.

Published: April 2011

AI Article Synopsis

  • A recent U.S. report in the Proceedings of the National Academy of Sciences claims scientists can definitively identify the source of an HIV infection.
  • This claim has been met with skepticism from international experts who challenge its validity.
  • The controversy highlights ongoing debates in the scientific community regarding methods and accuracy in tracking HIV transmissions.

Article Abstract

According to a recent report from the United States of America published in the Proceedings of the National Academy of Sciences, scientists could prove with certainty which person was the source of an HIV infection. However, international experts have disputed the claim.

Download full-text PDF

Source

Publication Analysis

Top Keywords

source hiv
8
hiv infection
8
phylogenetic analysis
4
analysis prove
4
prove source
4
infection experts
4
experts report
4
report united
4
united states
4
states america
4

Similar Publications

Background: New indicators of potential human immunodeficiency virus (HIV) transmission are being actively explored. We aim to categorical testing of the viral load (VL) of persons living with HIV (PLWH) in order to explore new indicators to measure the intensity of the epidemic and the effectiveness of the response in the community.

Methods: A dynamic cohort study was conducted in Yining to monitor the VL of all persons living with HIV from 2017 to 2019.

View Article and Find Full Text PDF

Background: Women living with HIV bear a disproportionate burden of stigma, especially in countries where gender discrimination is more common. A result is widespread domestic violence against women. This violence is itself stigmatized, but the intersectional stigma of HIV and domestic violence has not been well studied.

View Article and Find Full Text PDF

Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.

J Hepatol

January 2025

Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; CRC "A. M. and A. Migliavacca" Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; D-SOLVE consortium, an EU Horizon Europe funded project (No 101057917). Electronic address:

Background And Aims: Bulevirtide (BLV) 2 mg/day is EMA approved for treatment of compensated chronic hepatitis due to Delta virus (HDV) infection, however real-life data in large cohorts of patients with cirrhosis are lacking.

Methods: Consecutive HDV-infected patients with cirrhosis starting BLV 2 mg/day since September 2019 were included in a European retrospective multicenter real-life study (SAVE-D). Patient characteristics before and during BLV treatment were collected.

View Article and Find Full Text PDF

Background: HIV pre-exposure prophylaxis (PrEP) is a highly effective intervention to prevent HIV transmission among men who have sex with men (MSM). Despite its effectiveness, PrEP uptake and adherence among MSM in the United States remain suboptimal, particularly in rural areas.

Objective: The present study presents a scoping review of the self-reported barriers and facilitators of PrEP use among MSM living in rural areas of the United States.

View Article and Find Full Text PDF

Misinformation, under-information, and disinformation regarding HIV among adolescents may be associated with a high prevalence of HIV among adolescents and young adults. The source of the HIV-related knowledge determines the accuracy and comprehensiveness of the information received. This study aimed to assess the adequacy (accuracy and comprehensive) of HIV-related knowledge and its determinants among senior school students in Abakaliki.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!